Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Saukkonen, Jussi
36  Ergebnisse:
Personensuche X
?
1

Establishing the safety of phenobarbital treatment of alcoh..:

Ronan, Matthew V. ; Ganatra, Rahul B. ; Saukkonen, Jussi
Alcohol.  116 (2024)  - p. 29-34 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Community-acquired Pneumonia Guideline Recommendations—Impa..:

Wilson, Kevin C ; Schoenberg, Noah C ; Cohn, David L...
Clinical Infectious Diseases.  73 (2020)  7 - p. e1467-e1475 , 2020
Link: https://doi.org/10.1093/..
 
?
3

Nonparticipation reasons in a randomized international tria..:

Hedges, Kimberley N Chapman ; Borisov, Andrey S ; Saukkonen, Jussi J...
Clinical Trials.  17 (2019)  1 - p. 39-51 , 2019
Link: https://doi.org/10.1177/..
 
?
4

Factors Associated With Noncompletion of Latent Tuberculosi..:

Moro, Ruth N. ; Borisov, Andrey S. ; Saukkonen, Jussi...
Clinical Infectious Diseases.  62 (2016)  11 - p. 1390-1400 , 2016
Link: https://doi.org/10.1093/..
 
?
5

Official American Thoracic Society/Centers for Disease Cont..:

Nahid, Payam ; Dorman, Susan E. ; Alipanah, Narges...
Clinical Infectious Diseases.  63 (2016)  7 - p. e147-e195 , 2016
Link: https://doi.org/10.1093/..
 
?
6

Factors Associated With Noncompletion of Latent Tuberculosi..:

Moro, Ruth N. ; Borisov, Andrey S. ; Saukkonen, Jussi...
Clinical Infectious Diseases.  62 (2016)  11 - p. 1390-1400 , 2016
Link: https://www.jstor.org/st..
 
?
7

Executive Summary: Official American Thoracic Society/Cente..:

Nahid, Payam ; Dorman, Susan E. ; Alipanah, Narges...
Clinical Infectious Diseases.  63 (2016)  7 - p. 853-867 , 2016
Link: https://doi.org/10.1093/..
 
?
8

Official American Thoracic Society/Centers for Disease Cont..:

Nahid, Payam ; Dorman, Susan E. ; Alipanah, Narges...
Clinical Infectious Diseases.  63 (2016)  7 - p. 853-867 , 2016
Link: https://www.jstor.org/st..
 
?
9

Predictors of latent tuberculosis treatment initiation and ..:

Goswami, Neela D ; Gadkowski, Lara Beth ; Piedrahita, Carla...
BMC Public Health.  12 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
10

Justifying Research Risks in a Clinical Trial for Treatment..:

Heilig, Charles M. ; Chia, David ; El-Sadr, Wafaa M....
IRB: Ethics & Human Research.  33 (2011)  4 - p. 10-17 , 2011
Link: https://www.jstor.org/st..
 
?
11

Challenges in Reintroducing Tuberculosis Medications after ..:

Saukkonen, Jussi
Clinical Infectious Diseases.  50 (2010)  6 - p. 840-842 , 2010
Link: https://doi.org/10.1086/..
 
?
12

EDITORIAL COMMENTARY: Challenges in Reintroducing Tuberculo..:

Saukkonen, Jussi
Clinical Infectious Diseases.  50 (2010)  6 - p. 840-842 , 2010
Link: https://www.jstor.org/st..
 
?
13

Predictors of failure to complete treatment for latent tube..:

Parsyan, Armen E. ; Saukkonen, Jussi ; Barry, M. Anita..
Journal of Infection.  54 (2007)  3 - p. 262-266 , 2007
Link: https://doi.org/10.1016/..
 
?
14

Acute Respiratory Failure from Abused Substances:

Wilson, Kevin C. ; Saukkonen, Jussi J.
Journal of Intensive Care Medicine.  19 (2004)  4 - p. 183-193 , 2004
Link: https://doi.org/10.1177/..
 
?
15

Short‐Course Rifampin and Pyrazinamide Compared with Isonia..:

Jasmer, Robert M. ; Snyder, David C. ; Saukkonen, Jussi J....
Clinical Infectious Diseases.  38 (2004)  3 - p. 363-369 , 2004
Link: https://doi.org/10.1086/..
 
1-15